Last $2.99 USD
Change Today +0.0369 / 1.25%
Volume 100.1K
BTX On Other Exchanges
Symbol
Exchange
BTX is not on other exchanges.
As of 1:32 PM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter S. Garcia

Chief Financial Officer and Vice President, PDL BioPharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

52$708,613
As of Fiscal Year 2013

Background*

Mr. Peter S. Garcia, also known as Pete, has been the Chief Financial Officer and Vice President at PDL BioPharma, Inc. since May 13, 2013. Mr. Garcia served as the Chief Financial Officer and Principal Accounting Officer of Asterias Biotherapeutics, Inc. Mr. Garcia served as Acting Chief Accounting Officer of PDL BioPharma, Inc. from May 13, 2013 to July 24, 2013. He served as the Chief Financial Officer of BioTime, Inc. from October 4, 2011 to June 11, 2013 and also ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA 1983
The Leland Stanford Junior University
MBA 1985
UCLA Anderson School of Management

Other Affiliations*

Annual Compensation*

Salary$248,182
Bonus$75,000
Total Annual Compensation$323,182

Stock Options*

Restricted Stock Awards$105,000
All Other Compensation$40,581

Total Compensation*

Total Annual Cash Compensation$603,613
Total Short Term Compensation$323,182
Other Long Term Compensation$145,581
Total Calculated Compensation$708,613
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $2.99 USD +0.0369

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
$489.3K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Tim Van Hauwermeiren MSc, EMBAChief Executive Officer and Director of Management Board
arGEN-X N.V
€256.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.